Qu Biologics Begins Phase 2 Clinical Trial in Ulcerative Colitis
Vancouver, British Columbia – July 28, 2015 – Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to restore normal immune function in the
Qu Biologics Opens Clinical Trial Sites in Edmonton and Toronto
Vancouver, British Columbia – April 24, 2015 – Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to restore the body’s normal immune function
Qu Biologics Welcomes Gastroenterologist Dr. Remo Panaccione to IBD Advisory Team
Vancouver, British Columbia – December 4, 2014 – Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to restore normal immune function in the
Qu Biologics’ Crohn’s Disease Clinical Trial Completes Independent Safety Review
Vancouver, British Columbia – October 29, 2014 – Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to restore the body’s immune system,
Qu Biologics to Present in Victoria, Kamloops, Calgary and Edmonton
Crohn’s and Colitis Canada – Western Canada invites you to an evening of inspiration and learning. Dr. Hal Gunn, immune system expert and founder of Qu Biologics will present “The Immune
Qu Biologics Presents Crohn’s Disease Compassionate Use Results at DDW
Vancouver, British Columbia – April 28, 2014 – Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to “reboot” the body’s immune system,
Qu Biologics Opens Crohn’s Disease Clinical Trial to U.S. Participants
Vancouver, British Columbia – February 18, 2014 – Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs) that aim to “reboot” the body’s innate
FREE SEMINAR: Microbial involvement in Crohn’s disease
Qu Biologics is pleased to welcome microbiology expert Dr. Brian Coombes to Vancouver to give a seminar on his recently published research in Nature Communications demonstrating that infection of
Gastroenterology Panel Discussion about the use of SSIs for Crohn’s disease
Listen to this informative panel discussion about the use of site specific immunomodulators (SSIs), an investigational treatment aimed at stimulating the immune system to reverse the chronic
Podcast: The Natural Health Show Special Report on Crohn’s December 7th & 8th, 2013
Update December 10th - Podcast of the show now available. Listen here. ______ Tune into The Natural Health Show this weekend for a special report on the impact of Crohn's disease. Host Steve